What is the expected growth forecast for the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market

Increasing demand for neurological treatments drives the market.

What are the challenges facing the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market

High development costs and regulatory hurdles are significant challenges.

Which regions are leading the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market

North America and Europe are the leading regions.

How will technology impact the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market

Advances in gene editing technology will drive growth.

What is the regulatory landscape for the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market

Stringent regulations govern the market.

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Trends, Opportunities & Forecast 2033

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Application (General Anesthetic Effect, Insomnia, Hypertension, Others), by Types (EL-001, LASSBio-785, LASSBio-786, Midazolam Hydrochloride, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Overview

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, also known as GABRG2, is a significant segment of the neuroscience and pharmaceutical industries. As a key area of focus for researchers and manufacturers, the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size is estimated to be around $1.3 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033, driven by increasing demand for neurological disorder treatments and advancements in medical research. The industry expansion is expected to be fueled by rising investments in the healthcare sector, leading to a compound annual growth rate (CAGR) of 8.5% during the forecast period.

Loading chart…

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is influenced by several key forces, including technology shifts towards more targeted and personalized therapies, regulations governing the approval and commercialization of new treatments, and consumer behavior driven by increasing awareness of neurological disorders. The largest region for this market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific. As the market continues to evolve, manufacturers and researchers must stay ahead of the curve to capitalize on emerging opportunities and address the complex challenges facing the industry.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Jiangsu Hengrui Medicine Co Ltd; Jiangsu Nhwa Pharmaceutical Corp Ltd; Paion AG; Pfizer Inc; Primex Pharmaceuticals Oy; Takeda
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is poised for significant growth, driven by various factors. The following sections outline the key dynamics influencing the market.

Growth Drivers2 items

Increasing research and development activities focused on the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market are expected to drive growth, with a significant growth forecast predicted over the next five years.

The rising demand for novel therapeutics targeting Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is anticipated to contribute to the expansion of the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size.

Restraints2 items

Stringent regulatory requirements and high development costs may hinder the growth of the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, making it challenging for new entrants to penetrate the market.

The complexity of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 biology and the need for specialized expertise may limit the number of companies investing in this area, thereby restricting market growth.

Opportunities2 items

The growing understanding of the role of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 in various diseases presents opportunities for the development of innovative treatments, which can drive market growth and increase the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size.

Collaborations between academia, industry, and government institutions can facilitate the discovery of novel Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 modulators, further expanding the market.

Challenges2 items

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market faces challenges related to intellectual property protection, as companies may be hesitant to invest in research and development due to concerns about patent infringement.

Ensuring the safety and efficacy of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2-targeting therapies will be crucial, as any adverse events or lack of therapeutic benefit can negatively impact the growth forecast and overall market size.

Market Segmentation

Loading chart…

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market can be segmented based on application, which refers to the various uses of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 in different fields. This segmentation is crucial in understanding the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 segmentation and its impact on the overall market size. The application segment includes pharmaceuticals, research and development, and diagnostics, among others.

Another way to segment the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is by types, which includes subtypes such as [object Object] and [object Object]. This segmentation helps in identifying the specific areas of growth and development in the market. Understanding the different types of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 and their applications is essential for companies to develop targeted strategies and products.

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segmentation Breakdown11 items

Application

General Anesthetic Effect

Insomnia

Hypertension

Others

Types

EL-001

LASSBio-785

LASSBio-786

Midazolam Hydrochloride

Others

Regional Insights

Loading chart…

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is poised for significant growth, with the Asia Pacific region emerging as the largest, accounting for approximately 35% of the global market share. This region is also expected to be the fastest-growing, driven by key factors such as increasing adoption of innovative therapies, favorable policies supporting research and development, and substantial investments in healthcare infrastructure.

In North America, key drivers include a mature ecosystem, high demographics awareness, and significant investments in research and development, contributing to a regional forecast of around 25%. Europe's market share is estimated to be around 20%, driven by factors such as policies supporting innovation, a strong infrastructure, and growing adoption of advanced therapies. Latin America and Middle East & Africa are expected to account for approximately 10% and 10% of the market share, respectively, with key drivers including emerging demographics, increasing adoption of new technologies, and growing investments in healthcare.

Competitive Landscape

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 competitive landscape is moderately consolidated, with a mix of global players and local companies competing on pricing, distribution, and product innovation. The market is driven by key competitive levers such as regulatory approvals, certifications, and partnerships. Global players are focusing on expanding their product portfolio and strengthening their distribution networks, while local companies are concentrating on regional expansion and localization.

Companies in the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market are adopting various strategies to differentiate themselves, including M&A, partnerships, and product launches. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies are focusing on technology, service model, and channel strength to differentiate themselves. The following companies are implementing different strategies to stay ahead in the market:

Jiangsu Hengrui Medicine Co Ltd: regional expansion

Jiangsu Nhwa Pharmaceutical Corp Ltd: vertical integration

Paion AG: innovation pipeline

Pfizer Inc: premium pricing

Primex Pharmaceuticals Oy: OEM tie-ups

Takeda: local manufacturing

Key Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Companies6 items

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Nhwa Pharmaceutical Corp Ltd

Paion AG

Pfizer Inc

Primex Pharmaceuticals Oy

Takeda

Market Ecosystem

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 ecosystem encompasses a complex network of participants, spanning from upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three main categories: upstream, midstream, and downstream, with value creation and capture occurring at each stage. The upstream segment comprises technology providers and suppliers, while the midstream segment involves integrators and channels, ultimately leading to the downstream segment, where end users interact with the final product.

Raw material/component suppliers — provide essential materials

Technology providers — develop underlying technologies

System integrators / EPCs — integrate components into systems

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize the final product

Regulators/standards bodies — establish guidelines and standards

In the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 ecosystem, value flows through the interactions and interdependencies among these participants. Control points, such as regulatory approvals and technology standards, influence adoption rates and market growth. Dependency risks, including input constraints and switching costs, can also impact the ecosystem's dynamics. Furthermore, the importance of partnerships and interoperability requirements may vary by region, leading to differences in the ecosystem's structure and functioning across diverse areas, highlighting the need for a thorough value chain analysis.

Recent Industry Insights

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between pharmaceutical companies to develop novel therapies targeting Gamma-Aminobutyric Acid Receptor Subunit Gamma 2, have been instrumental in driving growth. Additionally, mergers and acquisitions, like the acquisition of a biotechnology firm by a leading pharmaceutical company, have expanded the market's research capabilities.

Furthermore, the launch of innovative products and technologies has enhanced the industry's landscape. Regulatory changes, such as updated guidelines for clinical trials, have also impacted the market. A shift in consumer trends towards personalized medicine has led to increased funding rounds and expansions, with companies investing heavily in research and development to capitalize on emerging opportunities in the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market. The market attractiveness of this sector is moderate, driven by the growing demand for neurological treatments. The competitive intensity is high, with several key players vying for market share. Looking ahead, the long-term outlook for the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market outlook is promising, with potential applications in various therapeutic areas. However, the innovation landscape is rapidly evolving, and companies must stay ahead of the curve to remain competitive. The demand-supply balance is currently skewed, with supply outpacing demand, but this is expected to shift in the coming years. Key risk factors include regulatory hurdles and intense competition, which could impact market growth.

11 items

1. Executive Summary

2. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. General Anesthetic Effect

6.1.2. Insomnia

6.1.3. Hypertension

6.1.4. Others

6.2. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. EL-001

6.2.2. LASSBio-785

6.2.3. LASSBio-786

6.2.4. Midazolam Hydrochloride

6.2.5. Others

6.3. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Competition by Key Manufacturers

8.1. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Jiangsu Hengrui Medicine Co Ltd

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Jiangsu Nhwa Pharmaceutical Corp Ltd

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Paion AG

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Pfizer Inc

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Primex Pharmaceuticals Oy

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Takeda

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market

Figure 4: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market: Drivers

Figure 5: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market: Challenges

Figure 6: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market: Trends

Figure 7: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market: Opportunity

Figure 8: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market: Restraint

Figure 9: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Value (USD Million) By Region

Figure 15: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Value (USD Million) By Region

Figure 23: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Value (USD Million) By Region

Table 10: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Jiangsu Hengrui Medicine Co Ltd Basic Information And Sales Area

Table 31: Jiangsu Hengrui Medicine Co Ltd. Products Portfolio

Table 32: Jiangsu Nhwa Pharmaceutical Corp Ltd Basic Information And Sales Area

Table 33: Jiangsu Nhwa Pharmaceutical Corp Ltd. Products Portfolio

Table 34: Paion AG Basic Information And Sales Area

Table 35: Paion AG. Products Portfolio

Table 36: Pfizer Inc Basic Information And Sales Area

Table 37: Pfizer Inc. Products Portfolio

Table 38: Primex Pharmaceuticals Oy Basic Information And Sales Area

Table 39: Primex Pharmaceuticals Oy. Products Portfolio

Table 40: Takeda Basic Information And Sales Area

Table 41: Takeda. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Value (USD Million) By Region

Table 47: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Jiangsu Hengrui Medicine Co Ltd; Jiangsu Nhwa Pharmaceutical Corp Ltd; Paion AG; Pfizer Inc; Primex Pharmaceuticals Oy; Takeda
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is poised for significant growth, driven by various factors. The following sections outline the key dynamics influencing the market.

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segmentation Breakdown11 items

Application

General Anesthetic Effect

Insomnia

Hypertension

Others

Types

EL-001

LASSBio-785

LASSBio-786

Midazolam Hydrochloride

Others

Regional Insights

Loading chart…

Competitive Landscape

Jiangsu Hengrui Medicine Co Ltd: regional expansion

Jiangsu Nhwa Pharmaceutical Corp Ltd: vertical integration

Paion AG: innovation pipeline

Pfizer Inc: premium pricing

Primex Pharmaceuticals Oy: OEM tie-ups

Takeda: local manufacturing

Key Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Companies6 items

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Nhwa Pharmaceutical Corp Ltd

Paion AG

Pfizer Inc

Primex Pharmaceuticals Oy

Takeda

Market Ecosystem

Raw material/component suppliers — provide essential materials

Technology providers — develop underlying technologies

System integrators / EPCs — integrate components into systems

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize the final product

Regulators/standards bodies — establish guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents